Rebecca Killion, MA, McKenna Long & Aldridge, says that patients' adherence to diabetes treatment is anything but simple.
Rebecca Killion, MA, McKenna Long & Aldridge, says that patients’ adherence to diabetes treatment is anything but simple. The kinds of medications they take can vary, and there are numerous variables that affect their ability to adhere to them appropriately.
“It’s not that patients don’t want to be compliant or that they don’t adhere,” says Mr Killion. “Life is complicated, it interferes. Sometimes you forget your medication: ‘Did I take that dose? Did I take that shot?’ And then you don’t want to overdose. It’s a much more complicated process than being a bad patient or not being compliant.”
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen